Skip to content

Author

Ming Xu

We have 2 of 22 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Intervening in Adipocyte Senescence: Lipid Prodrugs as an Emerging Strategy for Metabolic Disease Treatment.

Lipid prodrugs are proposed as promising adipose tissue delivery platforms that can be coupled with diverse therapeutic agents to increase the local concentration of drugs and minimize systemic toxicity by utilizing the unique lipid metabolism of adipocytes.

Xin-Ying Mo, Dan Huang, Si-Fei Han et al. · 0 citations
Open access Aug 2026

Frailty prediction in heart failure patients with acute infections: the potential role of thiazide diuretics?

The use of thiazide diuretics was identified as an independent predictor associated with lower frailty probability and an online calculator was developed as a proof-of-concept tool to demonstrate the potential application of the predictive model and facilitate real-time risk estimation.

Ting Huang, Shuyi Liu, Siyu Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.